[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356741-105":59,"doc-detail-356741-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","delineation-of-the-heterogeneity-underlying-genomic-instability-in-hereditary-breast-cancers-reveals-four-disease-subtypes-research-findings","Delineation of the heterogeneity underlying genomic instability in hereditary breast cancers reveals four disease subtypes - Research Findings","","Hereditary breast cancers show genomic heterogeneity, yet the specific genomic instability driving clinical differences remains insufficiently defined. Whole-genome sequencing was performed on 129 BRCA1/2-negative hereditary breast cancers, with methylome and transcriptome analyses on subsets and integration of COSMIC mutational, copy number, and structural variation signatures. Four subtypes emerged: HRD, MUT, CN-dominant, and genome stable. Each subtype displayed distinct instability features, immune or stromal infiltration patterns, and therapy-relevant vulnerabilities. An integrative genomic instability index supports patient stratification and personalized strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/delineation-of-the-heterogeneity-underlying-genomic-instability-in-hereditary-breast-cancers-reveals-four-disease-subtypes-research-findings/356741/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/delineation-of-the-heterogeneity-underlying-genomic-instability-in-hereditary-breast-cancers-reveals-four-disease-subtypes-research-findings/356741.png","ImageObject",300,407,{"name":92,"@type":93},"นรินทร์","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were hereditary breast cancer subtypes defined in this study?","Question",{"text":112,"@type":113},"The study integrated whole-genome sequencing with COSMIC mutational, copy number, and structural variation signatures, supported by methylome and transcriptome analyses on subsets to define four genomic instability–based subtypes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What distinguishes the four identified disease subtypes?",{"text":117,"@type":113},"They differ in dominant instability drivers: HRD shows homologous recombination deficiency patterns including promoter hypermethylation and loss of heterozygosity; MUT is mutation-burden–dominant with APOBEC-associated kataegis and immune-activation programs; CN is copy-number–dominant with small-scale loss of heterozygosity and recurrent focal losses; genome stable lacks these instability patterns.",{"name":119,"@type":110,"acceptedAnswer":120},"Which treatments showed subtype-specific sensitivity signals?",{"text":121,"@type":113},"Functional analysis in cell lines suggested PARP inhibitors and cytotoxic chemotherapy sensitivity in HRD and CN tumors, while immune-related features in MUT tumors indicated vulnerability to immunotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356741,1790884335,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","[www.nature.com/emm](www.nature.com/emm)  \nARTICLE OPEN  \nDelineation of the heterogeneity underlying genomic instability in hereditary breast cancers reveals four disease subtypes  \nSunmin Kim 1,13, Seeyoun Lee2,13, Hyeji Kim3,4, Su Jung Kang 1,5, Heejung Chae6,7, Bong-Jo Kim8, Jinhwa Kong8,9, Min-Chae Kang3, Tae-Min Kim 1,10,11,14 ✉ and Sun-Young Kong 3,4,12,14 ✉  \n© The Author(s) 2026  \n\n|  | Hereditary breast cancers (hBCs) exhibit genomic heterogeneity, but their underlying genomic instability and clinical implications remain unclear. We conducted whole-genome sequencing on 129 BRCA1/2-negative hBCs, with subsets analyzed by methylome and transcriptome sequencing, and integrated COSMIC mutational, copy number (CN), and structural variation signatures. Weidentiﬁed four subtypes: homologous recombination-deﬁcient (HRD), mutation-dominant (MUT), CN-dominant, and genome stable. HRD tumors exhibited genomic instability, including promoter hypermethylation and loss of heterozygosity at BRCA1/2 . Some HRDlow hBC genomes showed elevated mutations and CN changes, indicating HRD-independent mechanisms. MUT tumors showed high tumor mutation burdens with APOBEC-associated kataegis and cytolytic/immune-activation programs with M1 macrophage including upregulation of GZMA, GZMB, and large-scale transition. CN tumors were enriched for small-scale loss of heterozygosity maintaining euploidy with recurrent focal losses implicating classic tumor suppressors. Transcriptomics indicated immune and stromal inﬁltration in MUT and CN subtypes, respectively, suggesting subtype-speciﬁc therapeutic vulnerabilities. Functional analysis in cell lines suggests poly (ADP-ribose) polymerase inhibitors and cytotoxic chemotherapy sensitivity in HRD and CN tumors, whereas immune features in MUT tumors support vulnerability to immunotherapy. These ﬁndings suggest that distinct hBC subtypes delineated by genomic instability can advance insights into molecular heterogeneity beyond expression-based classiﬁcations and support an integrative genomic instability index (HRD score, ploidy, size-stratiﬁed CN burden, and signature |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| exposures) for patient stratiﬁcation and personalized therapeutic strategies. |  |  |\n|  | Experimental & Molecular Medicine (2026) 58:1254–1268; [https://doi.org/10.1038/s12276-026-01693-4](https://doi.org/10.1038/s12276-026-01693-4) |  |\n|  |  |  |\n\nINTRODUCTION  \nBreast cancer is one of the most prevalent malignancies and the primary cause of cancer-related deaths in women1,2. Approximately 5–10% of invasive cases are hereditary breast cancers (hBCs)3. Women with a ﬁrst-degree relative with breast cancer have a twofold increased risk of developing the disease4. Pathogenic germline variants in the well-known breast cancerrelated genes, BRCA1/BRCA2, account for 15–25% of hBC cases5 but other highly penetrant and pathogenic genetic variants have been identiﬁed. These include genes involved in DNA damage sensing (for example, ATM, ATR, CHEK1, and CHEK2) and those in the homologous recombination repair (HRR) pathway (for example, MRE11, RAD50, NSB1, BARD1, BLM, BRIP1, PALB2, and RAD51B/C/D) . Collectively, germline variants in these genes account for ~50% of hBC cases not explained by BRCA1 or BRCA2 mutations (BRCA1/BRCA2-negative hBC)6. Genes associated with  \ninherited cancer syndromes, such as TP53, PTEN, STK11, NF1, and CDH1, are also implicated in increased risk of hBCs7. Despite the heterogeneity of genes involved in the development of hBCs, their functional losses collectively result in homologous recombination deﬁciency (HRD), leading to the genomic instability and susceptibility to chemotherapy and poly (ADP-ribose) polymerase inhibitor (PARPi)8,9. The genomic consequences of HRD, known as chromosomal scars, can be quantiﬁed through HRD scores, which have been propos","cbCaiq2TVeAnzjIh","https://ap.wps.com/l/cbCaiq2TVeAnzjIh","pdf",4645532,15,"English","# Introduction\n## Disease heterogeneity and genomic instability in hereditary breast cancers\n## Limitations of existing HRD characterization\n# Methods and integrated multi-omics analysis\n# Results: four genomic-stability subtypes\n## HRD subtype features and HRD-independent mechanisms\n## MUT subtype features and immune activation\n## CN subtype features and focal loss patterns\n## Transcriptomic immune/stromal infiltration\n# Therapeutic implications and integrative instability index","[{\"question\":\"How were hereditary breast cancer subtypes defined in this study?\",\"answer\":\"The study integrated whole-genome sequencing with COSMIC mutational, copy number, and structural variation signatures, supported by methylome and transcriptome analyses on subsets to define four genomic instability–based subtypes.\"},{\"question\":\"What distinguishes the four identified disease subtypes?\",\"answer\":\"They differ in dominant instability drivers: HRD shows homologous recombination deficiency patterns including promoter hypermethylation and loss of heterozygosity; MUT is mutation-burden–dominant with APOBEC-associated kataegis and immune-activation programs; CN is copy-number–dominant with small-scale loss of heterozygosity and recurrent focal losses; genome stable lacks these instability patterns.\"},{\"question\":\"Which treatments showed subtype-specific sensitivity signals?\",\"answer\":\"Functional analysis in cell lines suggested PARP inhibitors and cytotoxic chemotherapy sensitivity in HRD and CN tumors, while immune-related features in MUT tumors indicated vulnerability to immunotherapy.\"}]","Delineation of the heterogeneity underlying genomic instability in hereditary breast cancers reveals four disease subtypes - Research Findings | PDF",1790127034,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8aa12b3a0d8755e10f81e5309dad605.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d933ed53fd124bffad8ec7e7f0e11f3.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45eca6f34205a1c0f5c278d0c99f4641.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3dd034efddf94875cf9f6b916f053c4c.webp",980,1301]